Vor Biopharma Inc (VOR) — Financial Flexibility Index
Vor Biopharma Inc (VOR) has a Financial Flexibility Index of -0.04x as of December 2025. Free cash flow of $-22.49 Million (operating CF $-22.80 Million minus capex $314.00K) represents 0% of total liabilities ($628.44 Million). Also explore Vor Biopharma Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vor Biopharma Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Vor Biopharma Inc across 8 annual periods. Check Vor Biopharma Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Vor Biopharma Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Vor Biopharma Inc. For the full company profile including market capitalisation, see Vor Biopharma Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.23x | $-141.77 Million | $-142.71 Million | $628.44 Million | ▲ +89.5% |
| 2024 | -2.15x | $-99.43 Million | $-99.66 Million | $46.23 Million | ▼ -28.1% |
| 2023 | -1.68x | $-99.22 Million | $-100.29 Million | $59.10 Million | ▼ -6.7% |
| 2022 | -1.57x | $-76.68 Million | $-85.14 Million | $48.76 Million | ▲ +36.5% |
| 2021 | -2.48x | $-65.25 Million | $-69.14 Million | $26.33 Million | ▼ -113.2% |
| 2020 | -1.16x | $-32.13 Million | $-36.29 Million | $27.64 Million | ▲ +72.1% |
| 2019 | -4.17x | $-9.11 Million | $-9.86 Million | $2.19 Million | ▼ -1593.0% |
| 2018 | -0.25x | $-1.91 Million | $-2.66 Million | $7.77 Million | — |